| 摘要 |
<p>Pharm. compns. contg. 20-800 mg 2-phenyl-5,6-dihydro-s-triazolo(5,1-a) isoquinoline, (A), 2-phenyl-s-triazolo (5,1-a) isoquinoline, (B) or their pharmaceutically acceptable acid-addition salts, together with a carrier, have postcoital, post-implanation antifertility activity in animals with no hormone-type side-effect.</p> |
